Recent Blood Diseases Research for August 2022
Hemophilia- Pipeline Insight, 2022
Topics: Blood Diseases, Drug Discovery
| 2022 Diseases of The Blood and Blood-Forming Organs and Certain Disorders Involving The Immune Mechanism (D50-D89) Global Market Size & Growth Report with COVID-19 Impact
Topics: Blood Diseases, Autoimmune, COVID-19/Coronavirus
Regions: Global
| Global Anti-Thrombin III Testing Market 2022-2026
Topics: Blood Diseases, Hypertension, Hospitals & Clinics, Coagulation
Regions: Global
| Lentiviral Vectors Market, By Product Type (1st-generation, 2nd-generation, and 3rd-generation), By Indication (HIV, ß-thalassemia, X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy, and Wiskott-Aldrich Syndrome), By End User (Hospitals, Clinics
Topics: AIDS, HIV & STDs, Blood Diseases, Hospitals & Clinics
| Plasma Protein Therapeutics Market Report 2022-2032
Topics: Proteomics, Antibody Technologies, Blood Diseases, Drug Discovery
| Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Blood Diseases, Drug Discovery
| 2022 Global Forecast for Anemia Drugs Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
Topics: Blood Diseases, Drug Discovery
Regions: Global
| Global Rare Hemophilia Factors Market 2022-2026
Topics: Blood Diseases
Regions: Global
| Global Blood Plasma Fractionation Market Report, History and Forecast 2016-2027
Topics: Blood Diseases, Coagulation
Regions: Global
| Global Hemophilia Market - 2022-2029
Topics: Blood Diseases
Regions: Global
| Hemophilia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
Topics: Blood Diseases
Regions: Global
| Global Acquired Orphan Blood Diseases Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Topics: Blood Diseases, Drug Discovery
Regions: Global
| 2022 Global: Plasma Fractionation - Innovative Markets Forecast (2028) report
Topics: Blood Diseases
Regions: Global
| Biosimilars Market Research Report by Indication (Autoimmune Diseases, Blood Disorders, and Chronic Diseases), Product, Manufacturing, State (Florida, New York, and Ohio) - United States Forecast to 2027 - Cumulative Impact of COVID-19
Topics: Biosimilars, Blood Diseases, Autoimmune, COVID-19/Coronavirus
Regions: United States
| The 2023-2028 World Outlook for Anemia Drugs
Topics: Blood Diseases, Drug Discovery
Regions: Global
| Thalassemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Blood Diseases, Drug Discovery, Clinical Trial
| Global Autoimmune Hemolytic Anemia Therapeutics Market 2022-2026
Topics: Blood Diseases, Autoimmune, Drug Discovery
Regions: Global
| Global Renal Anemia Therapeutics Market 2022-2026
Topics: Blood Diseases, Renal
Regions: Global
| The 2023-2028 World Outlook for Blood Cancer Therapeutics
Topics: Blood Diseases, Cancer Treatment, Oncology/Hematology
Regions: Global
| The 2023-2028 World Outlook for Bleeding Disorders Treatments
Topics: Blood Diseases
Regions: Global
| The 2023-2028 World Outlook for Hemophilia a Treatments
Topics: Blood Diseases
Regions: Global
| The 2023-2028 World Outlook for Hemophilia a Gene Therapies
Topics: Gene Therapy, Blood Diseases
Regions: Global
| 2022-2029 Global Hemophilia Therapeutics Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
Topics: Blood Diseases, Drug Discovery
Regions: Global
| Hemophilia Treatment Drugs Market Research Report by Product Type (Antifibrinolytic Agents, Desmopressin, and Plasma Derived Coagulation Factor Concentrates), Disease Indication, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle Eas
Topics: Blood Diseases, Prescription Drugs, Drug Discovery
Regions: Asia, Europe, Oceania
| Hemophilia Treatment Drugs Market Research Report by Product Type (Antifibrinolytic Agents, Desmopressin, and Plasma Derived Coagulation Factor Concentrates), Disease Indication, Distribution Channel, State (New York, Illinois, and Texas) - United States
Topics: Blood Diseases, Coagulation
Regions: United States
| Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, and Multiple Sclerosis), Type, Distribution Type, Distribution Channel, State (Illinois, Pennsylvania, and Florida) - United States Forecast to 2027 - Cumulative Impact of
Topics: AIDS, HIV & STDs, Blood Diseases, Multiple Sclerosis (MS), Hospitals & Clinics, Pharmacy & Distribution, Drug Stores, E-Commerce & Online Retailing
Regions: United States
| Iron Deficiency Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Blood Diseases, Drug Discovery
| The 2023-2028 World Outlook for Hemophilia Treatments
Topics: Blood Diseases
Regions: Global
| Hemophilia Treatment Market Size By Disease (Hemophilia A {Severe, Moderate, Mild}, Hemophilia B {Severe, Moderate, Mild}), By Product (Recombinant Factor Concentrates {Factor VIII, Factor IX}, Plasma-derived Factor Concentrates {Factor VIII, Factor IX},
Topics: Blood Diseases, COVID-19/Coronavirus, Hospitals & Clinics, Pediatrics
| Bleeding Disorders Treatment Market Research Report by Disease Type (Hemophilia A, Hemophilia B, and Von Willebrand Disease), Drug Class, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - C
Topics: Blood Diseases
Regions: Africa, Asia, Europe, Middle East, Oceania, Global
| Global Biosimilars Market Size study, By Product (Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Enoxaparin Sodium, Glucagon, Cal
Topics: Biosimilars, Antibody Technologies, Blood Diseases, Diabetes, Autoimmune
Regions: Global
| Sickle Cell Anemia Testing & Screening Market Research Report by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), and Point-of-Care Tests), Age Group, Sector, Region (Americas, Asia-Pacific, and Europe, Middle East &
Topics: Instrumentation & Equipment, Blood Diseases, Point-of-Care
Regions: Asia, Europe, Middle East, Oceania
| Sickle Cell Anemia Testing & Screening Market Research Report by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), and Point-of-Care Tests), Age Group, Sector, State (Florida, Texas, and Pennsylvania) - United States F
Topics: Instrumentation & Equipment, Blood Diseases, Point-of-Care
Regions: United States
| Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)
Topics: Antibody Technologies, Blood Diseases, COVID-19/Coronavirus
| Hemophilia Treatment Market - Global Industry Analysis (2019 - 2021) - Growth Trends and Market Forecast (2022 - 2027)
Topics: Antibody Technologies, Blood Diseases, Prescription Drugs, Drug Discovery
Regions: Global
| The 2023-2028 World Outlook for Hemophilia Drugs
Topics: Blood Diseases
Regions: Global
| Chemotherapy Induced Anemia - Pipeline Insight, 2022
Topics: Blood Diseases, Drug Discovery
| The 2023-2028 World Outlook for Hemophilia Gene Therapies
Topics: Gene Therapy, Blood Diseases
Regions: Global
| The 2023-2028 World Outlook for Bleeding Disorder Drugs
Topics: Blood Diseases
Regions: Global
| Biosimilars Market Research Report by Indication (Autoimmune Diseases, Blood Disorders, and Chronic Diseases), Product, Manufacturing, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID
Topics: Biosimilars, Blood Diseases, Autoimmune, COVID-19/Coronavirus
Regions: Africa, Asia, Europe, Middle East, Oceania, Global
| The 2023-2028 World Outlook for Blood Plasma Fractionation
Topics: Blood Diseases, Blood Banking & Tissue Typing
| The 2023-2028 World Outlook for Blood Cancers
Topics: Blood Diseases, Cancer Treatment
Regions: Global
| Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2027
Topics: Enzymes, Blood Diseases, Autoimmune, Hospitals & Clinics, Hematology & Oncology, CNS/Neurology, Oncology/Hematology, Allergy/Immunology, Rheumatology/Arthritis
Regions: Global
| Global Hemophilia A Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Topics: Blood Diseases
Regions: Global
| Hemophilia Market Research Report by Type (Hemophilia A, Hemophilia B, and Hemophilia C), Treatment, Therapy, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19
Topics: Blood Diseases, COVID-19/Coronavirus
Regions: Africa, Asia, Europe, Middle East, Oceania, Global
| Hemophilia Treatment Market Research Report by Product Type (Antifibrinolytic Agents, Desmopressin, and Plasma Derived Coagulation Factor Concentrates), Disease Indication, Distribution, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) -
Topics: Blood Diseases, Prescription Drugs, Drug Discovery
Regions: Africa, Asia, Europe, Middle East, Oceania
| Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, and Multiple Sclerosis), Type, Distribution Type, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumul
Topics: AIDS, HIV & STDs, Blood Diseases, Multiple Sclerosis (MS), Hospitals & Clinics, Pharmacy & Distribution, Prescription Drugs, E-Commerce & Online Retailing
Regions: Africa, Asia, Europe, Middle East, Oceania, Global
| Bleeding Disorders Treatment Market Research Report by Disease Type (Hemophilia A, Hemophilia B, and Von Willebrand Disease), Drug Class, Distribution Channel, State (Texas, New York, and Illinois) - United States Forecast to 2027 - Cumulative Impact of C
Topics: Blood Diseases
Regions: United States
| Hemophilia Market Research Report by Type (Hemophilia A, Hemophilia B, and Hemophilia C), Treatment, Therapy, State (California, Texas, and New York) - United States Forecast to 2027 - Cumulative Impact of COVID-19
Topics: Blood Diseases, COVID-19/Coronavirus
Regions: United States
| Hemophilia Treatment Market Research Report by Product Type (Antifibrinolytic Agents, Desmopressin, and Plasma Derived Coagulation Factor Concentrates), Disease Indication, Distribution, State (Texas, California, and Florida) - United States Forecast to 2
Topics: Blood Diseases, Coagulation
Regions: United States
|
Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
